Introduction
Nateglinide, identified by the National Drug Code (NDC) 60687-0684, is a medication manufactured and distributed by American Health Packaging. This article provides a comprehensive market analysis and price projections for Nateglinide, focusing on historical pricing trends, market factors, and future price predictions.
Drug Overview
Nateglinide is a medication used to treat type 2 diabetes. It belongs to the class of drugs known as meglitinides, which work by stimulating the pancreas to release insulin. The drug is available in various formulations, but the NDC 60687-0684 specifically refers to the version manufactured by American Health Packaging[4].
Historical Pricing Trends
To understand the pricing dynamics of Nateglinide, it is essential to examine historical price data. Here are some key points:
- Price Variability: Prices for Nateglinide can vary based on the vendor, packaging, and date. For instance, prices for other drugs manufactured by American Health Packaging have shown fluctuations over time, such as Colchicine (NDC 60687-0358), which had prices ranging from $1.73 to $3.56 per unit in 2024[1].
- Market Forces: The prices of prescription drugs are influenced by several factors, including the drug's patent status, competition from generic or brand-name alternatives, and the size of the patient market. For Nateglinide, the absence of recent patent expirations or significant changes in market competition suggests relatively stable pricing[3].
Market Factors Influencing Pricing
Several market factors contribute to the pricing of Nateglinide:
Patent Status and Market Exclusivity
Nateglinide's patent status is crucial in determining its price. If a drug is under patent protection, the manufacturer can set higher prices due to the lack of competition. However, if the patent has expired, generic versions can enter the market, leading to price reductions. As of the latest data, there is no indication that Nateglinide's patent status has changed recently[3].
Competition
The presence of therapeutically equivalent drugs, both generic and brand-name, can significantly impact pricing. For Nateglinide, the availability of other meglitinides and diabetes treatments can influence its market price. However, if there are limited alternatives, the manufacturer may maintain higher prices[3].
Regulatory Environment
Regulatory changes, such as those introduced by the Medicare Drug Price Negotiation Program, can also affect drug prices. For example, beginning in January 2026, Medicare will negotiate prices for certain high-cost drugs, which could set a precedent for broader price negotiations in the market[2].
Price Projections
Given the current market conditions and historical trends, here are some projections for Nateglinide's prices:
Short-Term Projections
In the short term, prices for Nateglinide are likely to remain relatively stable. Without significant changes in patent status, competition, or regulatory environment, the prices will probably fluctuate within a narrow range.
Long-Term Projections
In the long term, several factors could influence Nateglinide's prices:
- Generic Competition: If generic versions of Nateglinide enter the market, prices could decrease significantly.
- Regulatory Changes: Future regulatory changes, such as expanded price negotiation programs, could lead to lower prices.
- Market Consolidation: Consolidation among pharmaceutical companies could result in fewer competitors and potentially higher prices due to reduced competition[3].
Case Study: Impact of Medicare Negotiations
The Medicare Drug Price Negotiation Program provides a useful case study. For drugs selected under this program, negotiated prices have resulted in discounts ranging from 38% to 79% compared to list prices. While Nateglinide is not currently part of this program, similar negotiations in the broader market could lead to significant price reductions[2].
Key Takeaways
- Stable Short-Term Prices: Nateglinide prices are expected to remain stable in the short term due to the absence of significant market changes.
- Potential Long-Term Reductions: Long-term prices could decrease with the introduction of generic versions or broader regulatory changes.
- Market Factors: Patent status, competition, and regulatory environment are critical in determining Nateglinide's prices.
FAQs
What is Nateglinide used for?
Nateglinide is used to treat type 2 diabetes by stimulating the pancreas to release insulin.
Who manufactures Nateglinide with the NDC 60687-0684?
American Health Packaging manufactures Nateglinide with the NDC 60687-0684.
What factors influence the price of Nateglinide?
The price of Nateglinide is influenced by its patent status, competition from other diabetes treatments, and regulatory changes.
How might future regulatory changes affect Nateglinide's price?
Future regulatory changes, such as expanded price negotiation programs, could lead to lower prices for Nateglinide.
What is the impact of generic competition on Nateglinide's price?
The entry of generic versions of Nateglinide into the market could significantly reduce its price.
Sources
- DrugPatentWatch - Latest drug prices and trends for NDC 60687-0358.
- HHS ASPE - Medicare Drug Price Negotiation Program.
- GAO - Brand-Name Prescription Drug Pricing.
- FindACode - American Health Packaging - NDC Labeler/Manufacturer.
